BEVYXXA Trademark

Trademark Overview

On Friday, October 2, 2015, a trademark application was filed for BEVYXXA with the United States Patent and Trademark Office. The USPTO has given the BEVYXXA trademark a serial number of 86776749. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 8, 2023. This trademark is owned by Portola Pharmaceuticals, Inc.. The BEVYXXA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in oncology and hematology; pharmaceutical preparations for the treatment of coagulation disorders, thrombosis, hematologic cancers, and inflammation; pharmaceutical preparations for use as anticoagulants
bevyxxa

General Information

Serial Number86776749
Word MarkBEVYXXA
Filing DateFriday, October 2, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 8, 2023
Registration Number5210125
Registration DateTuesday, May 23, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 8, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in oncology and hematology; pharmaceutical preparations for the treatment of coagulation disorders, thrombosis, hematologic cancers, and inflammation; pharmaceutical preparations for use as anticoagulants

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 8, 2023
Primary Code005
First Use Anywhere DateThursday, March 30, 2017
First Use In Commerce DateThursday, March 30, 2017

Trademark Owner History

Party NamePortola Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NamePortola Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NamePortola Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Friday, December 8, 2023CANCELLED SEC. 8 (6-YR)
Monday, May 23, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, February 12, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 12, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 3, 2017COUNTERCLAIM OPP. NO. 999999
Tuesday, May 23, 2017REGISTERED-PRINCIPAL REGISTER
Thursday, April 20, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, April 19, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, April 19, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 19, 2017NON-FINAL ACTION E-MAILED
Wednesday, April 19, 2017SU - NON-FINAL ACTION - WRITTEN
Saturday, April 8, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 7, 2017STATEMENT OF USE PROCESSING COMPLETE
Friday, March 31, 2017USE AMENDMENT FILED
Friday, April 7, 2017SOU EXTENSION 2 GRANTED
Friday, March 31, 2017SOU EXTENSION 2 FILED
Wednesday, April 5, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, March 31, 2017SOU TEAS EXTENSION RECEIVED
Friday, March 31, 2017TEAS STATEMENT OF USE RECEIVED
Thursday, October 6, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 4, 2016SOU EXTENSION 1 GRANTED
Tuesday, October 4, 2016SOU EXTENSION 1 FILED
Tuesday, October 4, 2016SOU TEAS EXTENSION RECEIVED
Tuesday, May 3, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 8, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 8, 2016PUBLISHED FOR OPPOSITION
Wednesday, February 17, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, January 23, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 22, 2016ASSIGNED TO EXAMINER
Wednesday, October 7, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 6, 2015NEW APPLICATION ENTERED

Related Keywords

bevyxxa pharmaceutical preparations cancers hematologic inflammation anticoagulants thrombosis coagulation oncology hematology